# Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fed Condition

> **NCT01283932** · PHASE1 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 52 (actual)

## Conditions studied

- FED

## Interventions

- **DRUG:** Pantoprazole Sodium

## Key facts

- **NCT ID:** NCT01283932
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2004-12
- **Final completion:** 2004-12
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2011-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01283932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01283932, "Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fed Condition". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01283932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*